Sean Gaskell

Chief Tech/Sci/R&D Officer at Alvotech hf

42 year

Health Technology

Consumer Services

Profile

Sean Gaskell is currently the Chief Technical Officer at Alvotech hf.
Prior to his current position, he held the role of Vice President-Manufacturing Operations at Novartis Gene Therapies, Inc. from 2018 to 2020.
He also served as the Site Head at Novartis AG.
Dr. Gaskell has a background in undergraduate and doctorate studies from Loughborough University.

Sean Gaskell active positions

Companies	Position	Start
Alvotech hf Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland.	Chief Tech/Sci/R&D Officer	2020-04-30

All active positions of Sean Gaskell

Former positions of Sean Gaskell

Companies	Position	End
AVEXIS INC	Corporate Officer/Principal	2019-12-31
NOVARTIS AG	Corporate Officer/Principal	-
ALVOTECH	Chief Tech/Sci/R&D Officer	-

See the detail of Sean Gaskell's experience

Training of Sean Gaskell

Loughborough University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sean Gaskell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
ALVOTECH	Health Technology
NOVARTIS AG	Health Technology

Private companies	2
Novartis Gene Therapies, Inc. Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL.	Health Technology
Alvotech hf Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland.	Health Technology